CDMO

CDMO
Product Description

The manufacturing facility consists of six production blocks where we can produce APIs and intermediates ranging from kilo-lab to 10KL scale. Stainless steel and glass-lined reactors, each with a distinct capacity and capability, are available in each block. The utilities are planned not only for current manufacturing blocks but also for future expansion.

Read more Show less

APARNA PHARMACEUTICALS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
View company profile
Categories
more categories Show less
Specifications
  • Details
    • USFDA Approved Facility (2024)
    • EDQM Approved (Oct-2025)
    • General accreditations : WHO-GMP, Written Confrimation, ISO, etc. 
    • 375 KL Reaction volume.
    • Combination of Stainless Steel(SSR) & Glass Lined Reactors (GLR).
    • Six Class 100,000 Powder Processing Clean rooms.
    • R&D facility in a prime location with spacious 10,000 Sq.ft.Area, 25 fumehoods.
    •  Highly qualified R&D Team.
  • Selling Points
    We have expertise managing difficult chemical reactions, such as :

    • Acylation reactions
    • Alkylation reactions
    • Condensation reactions
    • Chiral Separations
    • Coupling Reactions
    • Hydrogenation without pressure
    • Nitration
    • High Vacuum Distillation
    • Methylation
    • Expertise in Chiral Synthesis
    • Cyanide Reactions
    • Chlorination
    • Bromination
    • High temperature reaction 250 C +
    • Oxidation
    • Reduction
    • Enzymatic Reactions
    • Silylation
    • Pressure Capacity upto 20 kg/cm2
    • Hofmann Rearrangement
    • Ketalization
    • Organolithium Reactions
    • Grignard Reaction
    • Oximationb
    • Hydrogenation Under Pressure
    • Hydrolysis
  • Model
    Contract manufacturing for API and Intermediates
  • Supplied from
    India
  • Measured In
    Ton
More specifications Fewer specifications
Sales Markets
Show more Show less

APARNA PHARMACEUTICALS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
View company profile

More Products from APARNA PHARMACEUTICALS LIMITED (1)

  • API

    Product API

    API's Products List:
    • Apixaban
    • Bilastine
    • Brexpiprazole
    • Brivaracetam
    • Cenobamate
    • Clopidogrel sulfate
    • Delafloxacin Meglumine
    • Dronedarone HCl
    • Fexuprazan HCl
    • Fimasartan potassium trihydrate
    • Finerenone
    • Fosfomycin Tromethamine q...